# Gambia Pertussis Study (GaPs)

> **NCT03606096** · PHASE4 · UNKNOWN · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 600 (estimated)

## Conditions studied

- Pertussis

## Interventions

- **BIOLOGICAL:** Boostrix IPV infant acellular Pertussis
- **BIOLOGICAL:** Boostrix IPV infant whole Pertussis
- **BIOLOGICAL:** TT infant acellular Pertussis
- **BIOLOGICAL:** TT infant whole Pertussis

## Key facts

- **NCT ID:** NCT03606096
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-23
- **Primary completion:** 2022-05-18
- **Final completion:** 2022-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2022-03-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606096, "Gambia Pertussis Study (GaPs)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03606096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*